Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy

Acta Derm Venereol. 2010 Mar;90(2):202-3. doi: 10.2340/00015555-0792.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / secondary
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Biopsy
  • Cetuximab
  • Cheek
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / metabolism
  • Female
  • Humans
  • Neck
  • Panitumumab
  • Skin / drug effects
  • Skin / pathology
  • Xanthomatosis / chemically induced*
  • Xanthomatosis / drug therapy
  • Xanthomatosis / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Panitumumab
  • EGFR protein, human
  • ErbB Receptors
  • Cetuximab